论文部分内容阅读
为了增进对实体肿瘤的疗效,作者分别试用了氟脲嘧啶加色霉素或色霉素半琥珀酸盐的二联方案和上述两种药物加强的松龙的三联药物方案。在二联与三联组中,氟脲嘧啶每日250毫克静滴。色霉素或色霉素半琥珀酸盐每日分别为0.5毫克和1.5毫克溶于20%葡萄糖液20毫升中静注。强的松龙每日30毫克口服,或20～30毫克肌注。患者均为组织学证实而不能手术或术后复发者。二联组中60例,主观症状改善率34.7%,客观体征改善23.6%(包括肿瘤体积缩小、胸腹腔渗液减少或消失)。三联组46例,症状改
In order to enhance the efficacy of solid tumors, the authors tested the two-combination regimen of fluorouracil plus chromomycin or chromomycin half-succinate, and the triple-drug regimen of the above-mentioned two drug-strengthened sulfasone. In the two- and triple-group, 250 mg of fluorouracil was instilled daily. Chromatin or hemazemycin hemi-succinate was intravenously dissolved in 20 ml of 20% glucose solution 0.5 mg daily and 1.5 mg daily. Prednisolone 30 mg orally daily, or 20-30 mg intramuscularly. All patients were histologically confirmed and were unable to undergo surgery or relapse. In the 60 cases of the second group, the improvement rate of the subjective symptoms was 34.7%, and the objective signs were improved by 23.6% (including the shrinkage of the tumor volume and the decrease or disappearance of the peritoneal effusion). Triad group 46 cases, symptoms changed